| Neal S Harnly, MD | |
|
418 Cloverleaf Rd, Elizabethtown, PA 17022-9320 | |
| (717) 653-1467 | |
| (717) 653-1001 |
| Full Name | Neal S Harnly |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 34 Years |
| Location | 418 Cloverleaf Rd, Elizabethtown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083694533 | NPI | - | NPPES |
| 742229 | Other | PA | HIGHMARK BLUE SHIELD |
| F55372 | Other | PA | HEALTH ASSURANCE |
| 0014127880002 | Medicaid | PA | |
| 02087902 | Other | PA | CAPITAL BLUE CROSS |
| 5866044 | Other | PA | AETNA NON-HMO |
| 22218 S101 | Other | PA | GEISINGER HEALTH PLAN |
| 516360 | Other | PA | AETNA HMO |
| P002668 | Other | PA | GATEWAY HEALTH PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD04942L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Medicine Home Health Lancaster General Health | Lancaster, PA | Home health agency |
| Masonic Village Home Health | Elizabethtown, PA | Home health agency |
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Masonic Village At Elizabethtown | Elizabethtown, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lancaster General Medical Group | 0941103683 | 463 |
News Archive
International medical technology company, Sectra, announces an agreement with Mammography Reporting System Inc. (MRS), a leading mammography tracking and reporting system provider, to distribute its solution, MRS7, fully integrated with Sectra Breast Imaging PACS.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world's most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.
A recent study directed by Mount Sinai School of Medicine identifies a faulty molecule in the brain found in cases of mild cognitive impairment (MCI).
Under normal circumstances, adult stem cells reside in muscle tissue, where they can differentiate into a number of different cell types. After an injury (or even a tough workout), muscles are inflamed as cells and molecules flood the area to control damage and begin repairs. When called upon to replace muscle tissue damaged by injury or genetic disease, some muscle stem cells differentiate, becoming new muscle cells, while others make more stem cells. At Sanford-Burnham Medical Research Institute (Sanford-Burnham), a team of scientists led by Pier Lorenzo Puri, M.D., Ph.D., recently uncovered the molecular messengers that translate inflammatory signals into the genetic changes that tell muscle stem cells to differentiate.
› Verified 6 days ago
| Entity Name | Lancaster General Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952392383 PECOS PAC ID: 0941103683 Enrollment ID: O20040309000916 |
News Archive
International medical technology company, Sectra, announces an agreement with Mammography Reporting System Inc. (MRS), a leading mammography tracking and reporting system provider, to distribute its solution, MRS7, fully integrated with Sectra Breast Imaging PACS.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world's most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.
A recent study directed by Mount Sinai School of Medicine identifies a faulty molecule in the brain found in cases of mild cognitive impairment (MCI).
Under normal circumstances, adult stem cells reside in muscle tissue, where they can differentiate into a number of different cell types. After an injury (or even a tough workout), muscles are inflamed as cells and molecules flood the area to control damage and begin repairs. When called upon to replace muscle tissue damaged by injury or genetic disease, some muscle stem cells differentiate, becoming new muscle cells, while others make more stem cells. At Sanford-Burnham Medical Research Institute (Sanford-Burnham), a team of scientists led by Pier Lorenzo Puri, M.D., Ph.D., recently uncovered the molecular messengers that translate inflammatory signals into the genetic changes that tell muscle stem cells to differentiate.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neal S Harnly, MD 418 Cloverleaf Rd, Elizabethtown, PA 17022-9320 Ph: (717) 653-1467 | Neal S Harnly, MD 418 Cloverleaf Rd, Elizabethtown, PA 17022-9320 Ph: (717) 653-1467 |
News Archive
International medical technology company, Sectra, announces an agreement with Mammography Reporting System Inc. (MRS), a leading mammography tracking and reporting system provider, to distribute its solution, MRS7, fully integrated with Sectra Breast Imaging PACS.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world's most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.
A recent study directed by Mount Sinai School of Medicine identifies a faulty molecule in the brain found in cases of mild cognitive impairment (MCI).
Under normal circumstances, adult stem cells reside in muscle tissue, where they can differentiate into a number of different cell types. After an injury (or even a tough workout), muscles are inflamed as cells and molecules flood the area to control damage and begin repairs. When called upon to replace muscle tissue damaged by injury or genetic disease, some muscle stem cells differentiate, becoming new muscle cells, while others make more stem cells. At Sanford-Burnham Medical Research Institute (Sanford-Burnham), a team of scientists led by Pier Lorenzo Puri, M.D., Ph.D., recently uncovered the molecular messengers that translate inflammatory signals into the genetic changes that tell muscle stem cells to differentiate.
› Verified 6 days ago
Diana Tacelosky, M.D., PH.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Continental Dr, Elizabethtown, PA 17022 Phone: 717-531-5164 Fax: 717-531-0646 | |
Sarah Anne Lombel, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Continental Dr, Elizabethtown, PA 17022 Phone: 717-361-0666 | |
John J Mast, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 418 Cloverleaf Rd, Elizabethtown, PA 17022 Phone: 717-653-1467 Fax: 717-653-1001 | |
Scott C Conley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 418 Cloverleaf Rd, Elizabethtown, PA 17022 Phone: 717-653-1467 Fax: 717-653-1001 | |
Christopher Michael Washington, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 432 Cloverleaf Rd, Elizabethtown, PA 17022 Phone: 717-544-6350 | |
Eric L Esch, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 418 Cloverleaf Rd, Elizabethtown, PA 17022 Phone: 717-653-1467 Fax: 717-653-1001 |